Autopsy report · NCT01134991

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients

“Difficulty in recruitment”

The sponsor’s own words in the registry.

Life of this trial

• 21 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Vyne Therapeutics Inc.

Sponsor type

Industry

Conditions

Rosacea

Interventions

Topical Minocycline Foam FXFM244

Participants

21

Sites

1

Countries

Israel

Trials that died the same way

• Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
  “Difficulties in recruitment” (98% match in meaning)
• Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
  “Difficulty with recruitment.” (97% match in meaning)
• Intestinal Dysbiosis During Obstructive Sleep Apnea Syndrome
  “recruitment difficulty” (97% match in meaning)
• Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain
  “difficulty of recruitment” (97% match in meaning)
• Evaluation of Blood Flow Characteristics in Glaucoma Using Optical Coherence Tomography Angiography (OCT-A).
  “Difficulties with recruitment” (97% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.